PRL-3 facilitates angiogenesis and metastasis by increasing ERK phosphorylation and up-regulating the levels and activities of Rho-A/C in lung cancer

References

• Matter W F, Estridge T, Zhang C, et al. Role of PRL-3, a human muscle-specific tyrosine phosphatase, in angiotensin-II signaling. Biochem Biophys Res Commun 2001; 283: 1061–1068
   PubMed Web of Science ®Google Scholar
• Zeng Q, Hong W, Tan Y H. Mouse PRL-2 and PRL-3, two potentially prenylated protein tyrosine phosphatases homologous to PRL-1. Biochem Biophys Res Commun 1998; 244: 421–427
   PubMed Web of Science ®Google Scholar
• Saha S, Bardelli A, Buckhaults P, et al. A phosphatase associated with metastasis of colorectal cancer. Science 2001; 294: 1343–1346
   PubMed Web of Science ®Google Scholar
• Kong L, Li Q, Wang L, et al. The value and correlation between PRL-3 expression and matrix metalloproteinase activity and expression in human gliomas. Neuropathology 2007; 27: 516–521
   PubMed Web of Science ®Google Scholar
• Miskad U A, Semba S, Kato H, et al. High PRL-3 expression in human gastric cancer is a marker of metastasis and grades of malignancies: an in situ hybridization study. Virchows Arch 2007; 450: 303–310
   PubMed Web of Science ®Google Scholar
• Wang Y, Li Z F, He J, et al. Expression of the human phosphatases of regenerating liver (PRLs) in colonic adenocarcinoma and its correlation with lymph node metastasis. Int J Colorectal Dis 2007; 22: 1179–1184
   PubMed Web of Science ®Google Scholar
• Wang L, Peng L, Dong B, et al. Overexpression of phosphatase of regenerating liver-3 in breast cancer: association with a poor clinical outcome. Ann Oncol 2006; 17: 1517–1522
   PubMed Web of Science ®Google Scholar
• Polato F, Codegoni A, Fruscio R, et al. PRL-3 phosphatase is implicated in ovarian cancer growth. Clin Cancer Res 2005; 11: 6835–6839
   PubMed Web of Science ®Google Scholar
• Schwering I, Brauninger A, Distler V, et al. Profiling of Hodgkin's lymphoma cell line L1236 and germinal center B cells: identification of Hodgkin's lymphoma-specific genes. Mol Med 2003; 9: 85–95
   PubMed Web of Science ®Google Scholar
• Wu X, Zeng H, Zhang X, et al. Phosphatase of regenerating liver-3 promotes motility and metastasis of mouse melanoma cells. Am J Pathol 2004; 164: 2039–2054
   PubMed Web of Science ®Google Scholar
• Radke I, Gotte M, Kersting C, et al. Expression and prognostic impact of the protein tyrosine phosphatases PRL-1, PRL-2, and PRL-3 in breast cancer. Br J Cancer 2006; 95: 347–354
   PubMed Web of Science ®Google Scholar
• Zeng Q, Dong J M, Guo K, et al. PRL-3 and PRL-1 promote cell migration, invasion, and metastasis. Cancer Res 2003; 63: 2716–2722
   PubMed Web of Science ®Google Scholar
• Guo K, Li J, Tang J P, et al. Catalytic domain of PRL-3 plays an essential role in tumor metastasis: formation of PRL-3 tumors inside the blood vessels. Cancer Biol Ther 2004; 3: 945–951
   PubMed Web of Science ®Google Scholar
• Kato H, Semba S, Miskad U A, et al. High expression of PRL-3 promotes cancer cell motility and liver metastasis in human colorectal cancer: a predictive molecular marker of metachronous liver and lung metastasis. Clin Cancer Res 2004; 10: 7318–7328
   PubMed Web of Science ®Google Scholar
• Fiordalisi J J, Keller P J, Cox A D. PRL tyrosine phosphatases regulate rho family GTPases to promote invasion and motility. Cancer Res 2006; 66: 3153–3161
   PubMed Web of Science ®Google Scholar
• Liang F, Liang J, Wang W Q, et al. PRL3 promotes cell invasion and proliferation by down-regulation of Csk leading to Src activation. J Biol Chem 2007; 282: 5413–5419
   PubMed Web of Science ®Google Scholar
• Peng L, Jin G, Wang L, et al. Identification of integrin alpha1 as an interacting protein of protein tyrosine phosphatase PRL-3. Biochem Biophys Res Commun 2006; 342: 179–183
   PubMed Web of Science ®Google Scholar
• Forte E, Orsatti L, Talamo F, et al. Ezrin is a specific and direct target of protein tyrosine phosphatase PRL-3. Biochim Biophys Acta 2008; 1783
   PubMed Web of Science ®Google Scholar
• Mylona E, Nomikos A, Alexandrou P, et al. Lymphatic and blood vessel morphometry in invasive breast carcinomas: relation with proliferation and VEGF-C and -D proteins expression. Histol Histopathol 2007; 22: 825–835
   PubMed Web of Science ®Google Scholar
• Weidner N. Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors. Breast Cancer Res Treat 1995; 36: 169–180
   PubMed Web of Science ®Google Scholar
• Ferrara N. VEGF and the quest for tumour angiogenesis factors. Nat Rev Cancer 2002; 2: 795–803
   PubMed Web of Science ®Google Scholar
• Karkkainen M J, Makinen T, Alitalo K. Lymphatic endothelium: a new frontier of metastasis research. Nat Cell Biol 2002; 4: E2–E5
   PubMed Web of Science ®Google Scholar
• Mohammed R A, Green A, El-Shikh S, et al. Prognostic significance of vascular endothelial cell growth factors -A, -C and -D in breast cancer and their relationship with angio- and lymphangiogenesis. Br J Cancer 2007; 96: 1092–1100
   PubMed Web of Science ®Google Scholar
• Jung Y D, Nakano K, Liu W, et al. Extracellular signal-regulated kinase activation is required for up-regulation of vascular endothelial growth factor by serum starvation in human colon carcinoma cells. Cancer Res 1999; 59: 4804–4807
   PubMed Web of Science ®Google Scholar
• Li Q, Dong X, Gu W, et al. Clinical significance of co-expression of VEGF-C and VEGFR-3 in non-small cell lung cancer. Chin Med J (Engl) 2003; 116: 727–730
   PubMed Web of Science ®Google Scholar
• He Y, Karpanen T, Alitalo K. Role of lymphangiogenic factors in tumor metastasis. Biochim Biophys Acta 2004; 1654: 3–12
   PubMed Web of Science ®Google Scholar
• He Y, Rajantie I, Ilmonen M, et al. Preexisting lymphatic endothelium but not endothelial progenitor cells are essential for tumor lymphangiogenesis and lymphatic metastasis. Cancer Res 2004; 64: 3737–3740
   PubMed Web of Science ®Google Scholar